Cancer Research UK and NovalGen collaborate to advance T-cell engager into the clinic - UCLTF
Cancer Research UK, one of the world’s largest funders of cancer research, and NovalGen, a pioneering clinical stage immunology company, have signed an agreement to bring NovalGen’s next-generation...
ucltf.co.uk